Literature DB >> 16303924

Transscleral-RPE permeability of PEDF and ovalbumin proteins: implications for subconjunctival protein delivery.

Juan Amaral1, Robert N Fariss, Maria M Campos, W Gerald Robison, Hyuncheol Kim, Robert Lutz, S Patricia Becerra.   

Abstract

PURPOSE: To investigate the in vitro, ex vivo, and in vivo transscleral-retinal pigment epithelium (RPE) permeability of PEDF and structurally related proteins for the exploration of novel routes of protein delivery to the retina.
METHODS: Monkey RPE cells were cultured on permeable supports to separate apical and basal compartments. Porcine scleral tissue was placed in Ussing chambers to separate uveal and orbital compartments. Transepithelial resistance and voltage were measured by an electrical resistance system, and paracellular tracer flux was evaluated with trypan blue. Subconjunctival administration in rat eyes was by injections of soluble protein or by implantation of polyvinyl alcohol devices containing protein. Fluorescein-conjugated (Fl-) PEDF and ovalbumin were determined by spectrofluorometry, laser scanning, immunoblotting, epifluorescence, and confocal microscopy. Permeability was assessed by fluoresceinated-protein flux.
RESULTS: Transepithelial resistance, impermeability to trypan blue, and confocal microscopy confirmed functional and structural tight junction formation of RPE cells cultured on permeable supports. Full-length Fl-PEDF and Fl-ovalbumin proteins diffused through RPE cell monolayers from either the apical or basal side. Fl-ovalbumin diffused through scleral tissues at constant rates. Subconjunctival Fl-PEDF or Fl-ovalbumin administration in vivo revealed movement of full-length protein into the choroid and retina as early as 1 hour.
CONCLUSIONS: The sclera and RPE were permeable in vitro, ex vivo, and in vivo to PEDF and ovalbumin proteins. These large proteins can traverse through the sclera-RPE to reach the retina. In addition, these data prompt the proposal that subconjunctival protein delivery may represent a feasible and minimally invasive route for PEDF administration in the clinic.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16303924     DOI: 10.1167/iovs.05-0492

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  19 in total

1.  Overexpression of pigment epithelium-derived factor inhibits retinal inflammation and neovascularization.

Authors:  Kyoungmin Park; Ji Jin; Yang Hu; Kevin Zhou; Jian-xing Ma
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

2.  Identification of a novel inhibitor of the canonical Wnt pathway.

Authors:  Kyoungmin Park; Kyungwon Lee; Bin Zhang; Ti Zhou; Xi He; Guoquan Gao; Anne R Murray; Jian-Xing Ma
Journal:  Mol Cell Biol       Date:  2011-05-16       Impact factor: 4.272

3.  Sustained subconjunctival protein delivery using a thermosetting gel delivery system.

Authors:  Erin R Rieke; Juan Amaral; S Patricia Becerra; Robert J Lutz
Journal:  J Ocul Pharmacol Ther       Date:  2010-02       Impact factor: 2.671

4.  Pigment epithelium-derived factor is related to macular microcirculation in patients with macular edema and branch retinal vein occlusion.

Authors:  Hidetaka Noma; Hideharu Funatsu; Tatsuya Mimura
Journal:  Int Ophthalmol       Date:  2012-05-19       Impact factor: 2.031

5.  Scleral permeability varies by mouse strain and is decreased by chronic experimental glaucoma.

Authors:  Mary E Pease; Ericka N Oglesby; Elizabeth Cone-Kimball; Joan L Jefferys; Matthew R Steinhart; Anthony J Kim; Justin Hanes; Harry A Quigley
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-21       Impact factor: 4.799

6.  Doxycycline-mediated inhibition of choroidal neovascularization.

Authors:  Sonia Samtani; Juan Amaral; Maria M Campos; Robert N Fariss; S Patricia Becerra
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-06-10       Impact factor: 4.799

7.  Ocular delivery of pRNA nanoparticles: distribution and clearance after subconjunctival injection.

Authors:  Liang Feng; S Kevin Li; Hongshan Liu; Chia-Yang Liu; Kathleen LaSance; Farzin Haque; Dan Shu; Peixuan Guo
Journal:  Pharm Res       Date:  2013-12-03       Impact factor: 4.200

8.  Trans-scleral permeability of Oregon green 488.

Authors:  Sung Jin Lee; Stephen J Kim; Esther S Kim; Dayle H Geroski; Bernard E McCarey; Henry F Edelhauser
Journal:  J Ocul Pharmacol Ther       Date:  2008-12       Impact factor: 2.671

Review 9.  Nanomedicines for back of the eye drug delivery, gene delivery, and imaging.

Authors:  Uday B Kompella; Aniruddha C Amrite; Rashmi Pacha Ravi; Shelley A Durazo
Journal:  Prog Retin Eye Res       Date:  2013-04-17       Impact factor: 21.198

10.  Effects of human recombinant PEDF protein and PEDF-derived peptide 34-mer on choroidal neovascularization.

Authors:  Juan Amaral; S Patricia Becerra
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-22       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.